Technical Analysis for NSCI - Netscientific Plc

Grade Last Price % Change Price Change
D 63.00 0.00% 0.00
NSCI closed unchanged on Tuesday, April 23, 2024, on 3 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
200 DMA Support Bullish 0.00%
Doji - Bearish? Reversal 0.00%
200 DMA Support Bullish 0.00%
200 DMA Support Bullish 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
200 DMA Support Bullish 0.80%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 14 hours ago
Possible NR7 about 14 hours ago
10 DMA Support 1 day ago
200 DMA Support 1 day ago
3x Volume Pace 2 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Netscientific Plc Description

NetScientific plc is a transatlantic healthcare technology company. The Company develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the United States and Europe with a primary focus on diagnostics, digital health and therapeutics. The Company is engaged in the development of intellectual property. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients; Glucosense, a provider of a non-invasive glucose monitoring wearable device; Vortex Biosciences, which is engaged in circulating tumor cell identification, selection and analysis for disease monitoring and personalized therapeutic prescribing; Glycotest, which provides non-invasive blood tests for liver cancers and fibrosis-cirrhosis, and ProAxsis, which is engaged in respiratory disease diagnosis and treatment monitoring.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Healthcare Medicine Science Cancer Disease Ships Monitoring Clinical Medicine Analytics Earl Identification Partnerships Intellectual Property Machine Learning Blood Healthcare Technology Respirator Tumor Cancers Learning Respiratory Disease E Learning Fibrosis Heart Failure Blood Tests Circulating Tumor Cell Congestive Heart Failure Liver Cancer

Is NSCI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 80.5
52 Week Low 48.0
Average Volume 30,418
200-Day Moving Average 61.95
50-Day Moving Average 66.86
20-Day Moving Average 64.58
10-Day Moving Average 62.55
Average True Range 2.63
RSI (14) 43.82
ADX 15.66
+DI 16.28
-DI 20.42
Chandelier Exit (Long, 3 ATRs) 61.33
Chandelier Exit (Short, 3 ATRs) 65.88
Upper Bollinger Bands 69.72
Lower Bollinger Band 59.43
Percent B (%b) 0.35
BandWidth 15.92
MACD Line -1.24
MACD Signal Line -1.19
MACD Histogram -0.0516
Fundamentals Value
Market Cap 15.09 Million
Num Shares 23.9 Million
EPS -0.13
Price-to-Earnings (P/E) Ratio -484.62
Price-to-Sales 12.03
Price-to-Book 0.85
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 63.17
Resistance 3 (R3) 63.15 63.07 63.14
Resistance 2 (R2) 63.07 63.03 63.08 63.13
Resistance 1 (R1) 63.04 63.01 63.06 63.06 63.12
Pivot Point 62.96 62.96 62.97 62.97 62.96
Support 1 (S1) 62.93 62.92 62.94 62.94 62.88
Support 2 (S2) 62.85 62.89 62.86 62.87
Support 3 (S3) 62.82 62.85 62.86
Support 4 (S4) 62.83